Hedge Funds Similar to Propel Bio ,

13F Portfolio OverlapQ1 2026Propel Bio , portfolio →
Institutional-grade research for retail investors

Most similar hedge funds by 13F overlap

Propel Bio Management, LLC is an institutional investor managing $159M across 38 U.S. equity positions as of Q1 2026. Based on the overlap of conviction holdings in their latest 13F filings, the hedge funds with portfolios most similar to Propel Bio , are Rosalind Advisors,, NEXTBio, Sio ,, with shared positions in $DCTH, $VOR, $CLDX, $VRDN, $EYPT, $OVID. The full ranking of 25 similar funds is below.

Notable overlap · 7 shared positions
$249M
38 positions
Notable overlap · 5 shared positions
$215M
24 positions
Notable overlap · 5 shared positions
$697M
76 positions
Notable overlap · 7 shared positions
$1.7B
36 positions
Notable overlap · 6 shared positions
$1.3B
41 positions
Notable overlap · 5 shared positions
$124M
27 positions
Notable overlap · 3 shared positions
$733M
43 positions
#8VR Adviser, LLCSmart money
Some overlap · 5 shared positions
$2.7B
33 positions
Some overlap · 3 shared positions
$1.2B
22 positions
Some overlap · 6 shared positions
$176M
73 positions
Some overlap · 4 shared positions
$1.5B
28 positions
Some overlap · 4 shared positions
$3.9B
38 positions
Some overlap · 6 shared positions
$372M
75 positions
Some overlap · 4 shared positions
$2.0B
51 positions
Some overlap · 4 shared positions
$134M
32 positions
Some overlap · 3 shared positions
$1.6B
39 positions
Some overlap · 5 shared positions
$6.1B
63 positions
Some overlap · 5 shared positions
$1.0B
22 positions
Some overlap · 3 shared positions
$435M
42 positions
Some overlap · 5 shared positions
$250M
83 positions
Some overlap · 5 shared positions
$2.0B
66 positions
Some overlap · 4 shared positions
$119M
23 positions
Some overlap · 4 shared positions
$904M
29 positions
Some overlap · 5 shared positions
$1.2B
161 positions
Some overlap · 4 shared positions
$1.2B
45 positions

Compare Propel Bio ,’s portfolio side by side

See the exact shared positions, conviction overlap, sector alignment, and where these funds diverge — and run the same analysis on any of 8,700+ institutions.

View Propel Bio ,’s holdings

Similarity is derived from each fund’s latest 13F-HR filing with the SEC. Funds are ranked by the overlap of distinctive conviction holdings; near-universal mega-cap positions are excluded so the ranking reflects shared strategy, not common index exposure. Data is informational only and not investment advice.